Further analysis of serum based EPCA-2 as a specific prostate cancer associated biomarker

被引：0
|
作者：
Leman, Eddy S.
Cannon, Grant W.
Trock, Bruce J.
Sokoll, Lori J.
Chan, Daniel W.
Mangold, Leslie A.
Partin, Alan W.
Nickel, J. Curtis
Dimitrakov, Jordan D.
Getzenberg, Robert H.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31632-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：472 / 472
页数：1
相关论文
共 50 条
  • [31] Towards the Development of a Multiplex Prostate Cancer Specific Biomarker
    Park, K.
    Banerjee, S.
    Demichelis, F.
    Rubin, M. A.
    MODERN PATHOLOGY, 2011, 24 : 216A - 216A
  • [32] Towards the Development of a Multiplex Prostate Cancer Specific Biomarker
    Park, K.
    Banerjee, S.
    Demichelis, F.
    Rubin, M. A.
    LABORATORY INVESTIGATION, 2011, 91 : 216A - 216A
  • [33] Prediction of extraprostatic cancer by serum [-2] pro prostate specific antigen in clinically localized prostate cancer
    Nakashima, Jun
    Yamazaki, Keiichi
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    Ohigashi, Takashi
    Murai, Masaru
    JOURNAL OF UROLOGY, 2007, 177 (04): : 380 - 381
  • [34] Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer
    Shiqin Liu
    Michelle Shen
    En-Chi Hsu
    Chiyuan Amy Zhang
    Fernando Garcia-Marques
    Rosalie Nolley
    Kashyap Koul
    Meghan A. Rice
    Merve Aslan
    Sharon J. Pitteri
    Charlie Massie
    Anne George
    James D. Brooks
    Vincent J. Gnanapragasam
    Tanya Stoyanova
    British Journal of Cancer, 2021, 124 : 896 - 900
  • [35] Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer
    Liu, Shiqin
    Shen, Michelle
    Hsu, En-Chi
    Zhang, Chiyuan Amy
    Garcia-Marques, Fernando
    Nolley, Rosalie
    Koul, Kashyap
    Rice, Meghan A.
    Aslan, Merve
    Pitteri, Sharon J.
    Massie, Charlie
    George, Anne
    Brooks, James D.
    Gnanapragasam, Vincent J.
    Stoyanova, Tanya
    BRITISH JOURNAL OF CANCER, 2021, 124 (05) : 896 - 900
  • [36] Prostate cancer in the serum prostate-specific antigen era
    Humphrey, PA
    MAYO CLINIC PROCEEDINGS, 1998, 73 (05) : 489 - 490
  • [37] Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer
    Li, Shibao
    Zhao, Yao
    Chen, Wenbai
    Yin, Lingyu
    Zhu, Jie
    Zhang, Haoliang
    Cai, Chenchen
    Li, Pengpeng
    Huang, Lingyan
    Ma, Ping
    JOURNAL OF CANCER, 2018, 9 (15): : 2659 - 2665
  • [38] Identifying a surrogate biomarker for neuropilin-2 axis in serum of prostate cancer patients
    Mullen, Sarah A.
    Das, Dipanwita
    Dutta, Samikshan
    High, Robin R.
    Smith, Lynette M.
    Teply, Benjamin A.
    Datta, Kaustubh
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels
    Vicini, FA
    Horwitz, EM
    Gonzalez, J
    Martinez, AA
    JOURNAL OF UROLOGY, 1997, 158 (02): : 319 - 325
  • [40] Circulating hepsin as a novel serum biomarker in prostate cancer patients
    Beard, John
    Eddington, Sam
    Bowman, Noah
    Cole, Adam
    O'Brien, Timothy
    Johnson, Blake P.
    CANCER RESEARCH, 2020, 80 (16)
12345